USANA Health Sciences Inc (USNA)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 66,324 82,333 84,339 90,899 93,071 91,403 96,426 101,392 107,614 116,568 134,708 159,062 170,192 191,225 195,810 181,676 176,491 168,524 158,627 150,198
Revenue (ttm) US$ in thousands 856,402 864,228 877,532 902,933 923,927 930,694 950,819 977,178 1,001,860 1,041,382 1,082,496 1,155,009 1,190,168 1,235,586 1,258,823 1,180,028 1,137,751 1,095,421 1,057,506 1,054,531
Operating profit margin 7.74% 9.53% 9.61% 10.07% 10.07% 9.82% 10.14% 10.38% 10.74% 11.19% 12.44% 13.77% 14.30% 15.48% 15.56% 15.40% 15.51% 15.38% 15.00% 14.24%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $66,324K ÷ $856,402K
= 7.74%

USANA Health Sciences Inc's operating profit margin has shown a gradual decline from 14.24% as of March 31, 2020, to 7.74% as of December 31, 2024. The company experienced relatively stable operating profit margins around the 15% range from June 2020 to March 2021. However, there has been a noticeable decrease in profitability since then, with a more significant decline starting in March 2022.

The declining trend in operating profit margin indicates that the company may be facing challenges in controlling its operating expenses relative to its revenue generation. This could be attributed to various factors such as increased competition, rising costs, or inefficiencies in operations. It is crucial for USANA Health Sciences Inc to carefully monitor its cost structure and operational efficiency to improve its profitability in the future.